Free Clinical Trials in the USA and Canada
hope it is ok to post this
http://cancerforums.net/about17824.html
Primary Prostate Cancer Clinical Trial in the USA and Canada:
High intensity focused ultrasound (HIFU) is a non-invasive acoustic ablation technique that uses intersecting, precision focused ultrasound waves to raise the temperature of the target to) 80-90 degrees C in 2-3 seconds, destroying the targeted tissues (prostate cancer). The tissue targeting is highly precise, minimizing collateral damage.
The overall hypothesis is that HIFU with Sonablate can safely, effectively and selectively ablate prostate cancer tissue, resulting in complete tissue necrosis, in patients diagnosed with localized T1c/T2a prostate cancer, with minimal morbidity.
The specific hypothesis is that the Sonablate has the ability to:
Completely destroy prostate cancer tissue, without causing damage to the intervening tissue, with a drop in PSA levels to <0.5ng/ml.
Result in negative biopsies for evidence of viable malignant cells after the treatment (12 months if Nadir is not reached or PSA rises from Nadir)
Safely treat localized prostate cancer patients, with minimal and acceptable adverse effects
Eligibility—to be considered for the U.S. primary trials, candidates must:
have T1c or T2c carcinoma of the prostate detected by biopsy;
be between 40-75 years of age;
have a Gleason score of six or less;
have prostate specific antigen (PSA) level of 10 ng/mL or less.
volumn of 40cm or less
locations in the USA:
Birmingham, AL
Naples, FL
Myrtle Beach, SC
Nashville, TN
Memphis, TN
San Antonio, TX
Madison, WI
(BTW, I think that Texas and Tennessee's trials are full, but phone to find out for sure.)
There is no cost to enroll in the study, nor does it require health insurance. To learn if you qualify, please contact us at 1-866-987-HIFU (4438).
--------------------------------------------------------------------------------
Canada also has trials, which have less strick guidelines:
To qualify you must have a PSA of 10. or less,
Gleason of 7 or less,
40 to 80 y.o.,
T1c & T2a,
and prostate total volume less than 40cc with an AP height less than or equal to 4.2cm. (If volume is greater than 40cc or height greater than 4.2 cm, one 3 monthly shot of an LHRH analogue may be provided, followed by re-imaging of the prostate to document total volume below 40cc.)
Contact: George Vrabec, MD gvrabec@hotmail.com
Abbotsford Regional Hospital Cancer Center
Abbotsford, British Columbia, Canada